Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells

Journal of Clinical Investigation

Volumn 110, Issue 10, 2002, Pages 1549-1557

  Cassard, Lydie ^a   Cohen Solal, Joël F G ^a   Galinha, Annie ^a   Sastre Garau, Xavier ^b   Mathiot, Claire ^b   Galon, Jérôme ^a   Dorval, Thierry ^b   Bernheim, Alain ^c   Fridman, Wolf H ^a   Sautès Fridman, Catherine ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOMODULATION; IMMUNOREGULATION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0036854459     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215454     Document Type: Article

References (34)

1. Ravetch, J.V., and Bolland, S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-290.
2. Amigorena, S., et al. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science. 256:1808-1812.
3. Van den Herik-Oudijk, I.E., Capel, P.J., van der Bruggen, T., and Van de Winkel, J.G. 1995. Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood. 85:2202-2211.
4. Fridman, W.H., et al. 1992. Structural bases of Fc gamma receptor functions. Immunol. Rev. 125:49-76.
5. White, C.A., Weaver, R.L., and Grillo-Lopez, A.J. 2001. Antibody-targeted immunotherapy for treatment of malignancy. Annu. Rev. Med. 52:125-145.
6. Safa, M.M., and Foon, K.A. 2001. Adjuvant immunotherapy for melanoma and colorectal cancers. Semin. Oncol. 28:68-92.
7. Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., and Ravetch, J.V. 1998. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA. 95:652-656.
8. van de Winkel, J.G., Bast, B., and de Gast, G.C. 1997. Immunotherapeutic potential of bispecific antibodies. Immunol. Today. 18:562-564.
9. Clynes, R.A., Towers, T.L., Presta, L.G., and Ravetch, J.V. 2000. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6:443-446.
10. Braslawsky, G.R., Yaackubowicz, M., Frensdorff, A., and Witz, I.P. 1976. Receptors for immune complexes on cells within a non-lymphoid murine tumor. J. Immunol. 116:1571-1578.
11. Dorval, G., Witz, I.P., Klein, E., and Wigzell, H. 1976. Tumor-bound immunoglobulins. I. Further analysis of the characteristics of binding of immunoglobulins to in vivo-grown tumor cells. Int. J. Cancer. 17:109-119.
12. Ran, M., et al. 1991. In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency. Cancer Res. 51:612-618.
13. Cassard, L., et al. 2000. Expression of low-affinity Fc gamma receptor by a human metastatic melanoma line. Immunol. Lett. 75:1-8.
14. Greenman, J., et al. 1991. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab′)2 derivative For recruitment of cytotoxic effectors. Mol. Immunol. 28:1243-1254.
15. Gross, N., Beck, D., Portoukalian, J., Favre, S., and Carrel, S. 1989. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells. Int. J. Cancer. 43:665-671.
16. Looney, R.J., Abraham, G.N., and Anderson, C.L. 1986. Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J. Immunol. 136:1641-1647.
17. Carrel, S., Accola, R.S., Carmagnola, A.L., and Mach, J.P. 1980. Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res. 40:2523-2528.
18. Astier, A., et al. 1994. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J. Immunol. 152:201-212.
19. Pulford, K., et al. 1986. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. Immunology. 57:71-76.
20. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
21. Pricop, L., et al. 2001. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J. Immunol. 166:531-537.
22. Watanabe, T., et al. 1982. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J. Exp. Med. 156:1884-1889.
23. Cahan, L.D., Irie, R.F., Singh, R., Cassidenti, A., and Paulson, J.C. 1982. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc. Natl. Acad. Sci. USA. 79:7629-7633.
24. Elder, D.E., et al. 1989. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res. 49:5091-5096.
25. Neauport-Sautes, C., Daeron, M., Teillaud, J.L., Blank, U., and Fridman, W.H. 1986. The occurrence, structural and functional properties of immunoglobulin Fc receptors on murine neoplastic cells. Int. Rev. Immunol. 1:237-271.
26. Azeredo da Silveira, S., et al. 2002. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J. Exp. Med. 195:665-672.
27. Hulett, M.D., and Hogarth, P.M. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127.
28. Pearse, R.N., et al. 1999. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. Immunity. 10:753-760.
29. Kalka, D., von Reitzenstein, C., Kopitz, J., and Cantz, M. 2001. The plasma membrane ganglioside sialidase cofractionates with markets of lipid rafts. Biochem. Biophys. Res. Commun. 283:989-993.
30. Zhou, W., and Carpenter, G. 2001. Heregulin-dependent translocation and hyperphosphorylation ofErbB-2. Oncogene. 20:3918-3920.
31. Malbec, O., Fridman, W.H., and Daeron, M. 1999. Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB. J. Immunol. 162:4424-4429.
32. Aman, M.J., Tosello-Trampont, A.C., and Ravichandran, K. 2001. FcγRI-IB 1/SHlP-mediated inhibitory signaling in B cells involves lipid rafts. J. Biol. Chem. 276:46371-46378.
33. Hudziak, R.M., et al. 1989. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9:1165-1172.
34. Scott, A.M., and Welt, S. 1997. Antibody-based immunological therapies. Curr. Opin. Immunol. 9:717-722.